• SPX
  • $5,948.71
  • 0.53 %
  • $31.60
  • DJI
  • $43,870.35
  • 1.06 %
  • $461.88
  • N225
  • $38,283.78
  • 0.68 %
  • $257.68
  • FTSE
  • $8,149.27
  • 0.79 %
  • $64.20
  • IXIC
  • $18,972.42
  • 0.03 %
  • $6.28
Neuronetics, Inc. (STIM) Stock Price, News & Analysis

Neuronetics, Inc. (STIM) Stock Price, News & Analysis

Currency in USD Disclaimer

$0.84

$0.04

(4.67%)

Day's range
$0.76
Day's range
$0.84
50-day range
$0.52
Day's range
$1.2
  • Country: US
  • ISIN: US64131A1051
52 wk range
$0.52
Day's range
$5.07


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -7.03
  • Piotroski Score 3.00
  • Grade Market Outperform
  • Symbol (STIM)
  • Company Neuronetics, Inc.
  • Price $0.84
  • Changes Percentage (4.67%)
  • Change $0.04
  • Day Low $0.76
  • Day High $0.84
  • Year High $5.07

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 01/06/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $8.00
  • High Stock Price Target $8.00
  • Low Stock Price Target $8.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.94
  • Trailing P/E Ratio -2.38
  • Forward P/E Ratio -2.38
  • P/E Growth -2.38
  • Net Income $-30,189,000

Income Statement

Quarterly

Annual

Latest News of STIM

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Neuronetics, Inc. Frequently Asked Questions

  • What is the Neuronetics, Inc. stock price today?

    Today's price of Neuronetics, Inc. is $0.84 — it has increased by +4.67% in the past 24 hours. Watch Neuronetics, Inc. stock price performance more closely on the chart.

  • Does Neuronetics, Inc. release reports?

    Yes, you can track Neuronetics, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Neuronetics, Inc. stock forecast?

    Watch the Neuronetics, Inc. chart and read a more detailed Neuronetics, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Neuronetics, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Neuronetics, Inc. stock ticker.

  • How to buy Neuronetics, Inc. stocks?

    Like other stocks, STIM shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Neuronetics, Inc.'s EBITDA?

    Neuronetics, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Neuronetics, Inc.’s financial statements.

  • What is the Neuronetics, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -0.4231232831, which equates to approximately -42.31%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Neuronetics, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Neuronetics, Inc.'s financials relevant news, and technical analysis. Neuronetics, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Neuronetics, Inc. stock currently indicates a “sell” signal. For more insights, review Neuronetics, Inc.’s technical analysis.

  • A revenue figure for Neuronetics, Inc. for its last quarter?

    Neuronetics, Inc. published it's last quarterly revenues at $18.53 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.